Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2024-2029 Switzerland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in ... Read More
-
2024-2029 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in ... Read More
-
2024-2029 Colombia Hematology and Flow Cytometry Analyzers and Reagents Market - 2024 Supplier Shares, 2024-2029 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges and Risks
... Opportunities for Suppliers, Market Challenges and Risks This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current ... Read More
-
2024-2029 Indonesia Hematology and Flow Cytometry Analyzers and Reagents Market - 2024 Supplier Shares, 2024-2029 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges and Risks
... Opportunities for Suppliers, Market Challenges and Risks This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current ... Read More
-
Liver Cancer Drugs Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... liver cancer, which has seen a 75% increase in incidence over the past two decades, according to WHO. This rise is primarily attributed to an aging population, heightened alcohol consumption, and the widespread incidence of ... Read More
-
Middle East and Africa Pharmaceuticals Market, By Product Type (Prescription Drugs, Over the Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biopharmaceuticals); By Therapeutic Area (Cardiology, Oncology, Neurology, Infectious Diseases, Respiratory, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesale/Distributors); By End User (Hospitals & Clinics, Retail Consumers, Academic & Research Institutes, Contract Manufacturing Organizations (CMOs)); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East & Africa), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesale/Distributors); By End User (Hospitals & Clinics, Retail Consumers, Academic & Research Institutes, Contract Manufacturing Organizations (CMOs)); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of ... Read More
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
... value of the human organoids market will increase from an estimated USD 1.19 billion in 2024 to USD 2.33 billion in 2029, at a CAGR of 14.4% through the forecast period. Advancement in funding for ... Read More
-
Cancer Therapies Market in Europe 2024-2028
... the cancer therapies market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type ( Autologous Therapies, Non-Stem Cell Therapies, Non-Stem Cell Therapies), By Therapeutic Area (Oncology, Dermatology), By Region, And Segment Forecasts, 2025 - 2030
... Autologous Cell Therapy Market Growth & Trends The global autologous cell therapy market size is expected to reach USD 18.23 billion by 2030, registering a CAGR of 22.01% from 2025 to 2030, according to a ... Read More
-
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024
... drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route ... Read More
-
Pancreatic Cancer - Competitive Landscape, 2024
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Pancreatic Cancer: Understanding Pancreatic Cancer: Overview Pancreatic cancer is a disease in which ... Read More
-
Radiopharmaceutical Therapies Market Size, Share, By Radioisotope Type (Iodine-131, Gallium-68, Technetium-99m, Zirconium 89, Copper 64, Radium 223, Fluorine 18, Lutetium-177, Rubidium-82, Indium-111, and Others), By Source (Nuclear Reactors, Cyclotrons, and Others), By Application (Oncology, Cardiology, Gastroenterology, Neurology, Nephrology and Others), By End-User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) and By Region - Trends, Analysis and Forecast till 2034
... radiopharmaceutical therapies market involves gathering, analyzing, and interpreting information about a market, including its consumers, competitors, and overall industry trends. It helps businesses understand their target audience, identify opportunities for growth, and make informed decisions ... Read More
-
Global Circulating Tumor Cells and Cancer Stem Cells Market Growth (Status and Outlook) 2024-2030
... at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells and Cancer Stem Cells is forecast to a readjusted size of US$ 38710 million by 2030 with a CAGR ... Read More
-
Global Cancer Stem Cell Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 1777.9 million by 2030 with a CAGR of 7.3% during review period. Cancer stem cells (CSCs) refer to the cells obtained from tumor ... Read More
-
Global Multi-cancer Early Detection Market 2025-2029
... early detection market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Refractory Multiple Myeloma - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Refractory Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Relapsed Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Burkitt Lymphoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Burkitt Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031
... Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031 The global IVD assay development market is projected to reach $8.39 billion ... Read More
-
Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis By Offering, Technology (PCR, Flow Cytometry, NGS) Application (Lymphoma, Leukemia, Multiple Myeloma, Solid Tumor) Sample (Blood, Bone Marrow) – Global Forecast to 2031
... Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis by Offering, Technology (PCR, Flow Cytometry, NGS), Application (Lymphoma, Leukemia, Multiple Myeloma, Solid Tumor), Sample (Blood, Bone Marrow)–Global Forecast to 2031 According to a new ... Read More
-
Global Cancer Stem Cells (CSCs) Market Growth 2024-2030
... downstream market, the Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
2024-2029 Hematology and Flow Cytometry: US, Europe, Japan - A Market Facing Regulatory and Competitive Challenges - Supplier Shares and Segment Forecasts by Test - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological ... Read More
-
2024-2029 Nucleic Acid Testing (NAT) Market: US, Europe, Japan - Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... Emerging Tests, Competitive Analysis This new seven-country study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next ... Read More
-
Metastatic Lung Adenocarcinoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
... Latin America, and Middle East & Africa) – Market Forecast, 2025–2034 The global metastatic lung adenocarcinoma treatment market size is expected to reach USD 14.17 billion by 2034, according to a new study by Polaris ... Read More
-
Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
... 9% between 2025 and 2034. Cancer diagnostics encompasses a range of tests and technologies designed to detect and identify cancer at its earliest stages. The primary aim is to determine the type, location, and progression ... Read More
Research Assistance
